Phase I/II Study of 24-Hour Infusion of Irinotecan Combined with Oral UFT for Metastatic Colorectal Cancer

Publisher： Karger

E-ISSN： 1421-9794|54|2|140-146

ISSN： 0009-3157

Source： Chemotherapy, Vol.54, Iss.2, 2008-02, pp. : 140-146

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase II Study of UFT with Leucovorin Plus Hepatic Arterial Infusion with Irinotecan, 5-Fluorouracil and Leucovorin for Non-Resectable Liver Metastases of Colorectal Cancer

By  

Chemotherapy, Vol. 55, Iss. 2, 2008-12 ,pp. : 76-82

Karger

Access to resources Recommend Favorite

Hepatic Arterial Infusion with Irinotecan in Patients with Liver Metastases of Colorectal Cancer: Results of an Extended Phase I Study

By  

Chemotherapy, Vol. 59, Iss. 1, 2013-07 ,pp. : 66-73

Karger

Access to resources Recommend Favorite

Sequential Treatment with Irinotecan and Doxifluridine: Optimal Dosing Schedule in Murine Models and in a Phase I Study for Metastatic Colorectal Cancer

By  

Chemotherapy, Vol. 51, Iss. 1, 2005-04 ,pp. : 32-39

Karger

Access to resources Recommend Favorite

Phase I/II Trial of Irinotecan and S-1 Combination Chemotherapy as a Second-Line Treatment for Advanced Colorectal Cancer

By  

Chemotherapy, Vol. 59, Iss. 5, 2014-05 ,pp. : 338-343

Karger

Access to resources Recommend Favorite

Comparison of a 48-Hour Infusion of 5-Fluorouracil without Folinic Acid with 24-Hour Folinic Acid/5-Fluorouracil in Patients with Metastatic Colorectal Cancer Refractory to Bolus Folinic Acid/5-Fluorouracil

By  

Chemotherapy, Vol. 49, Iss. 1-2, 2003-05 ,pp. : 85-89

Karger

Access to resources Recommend Favorite